• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性结节性黑色素瘤:伴有罕见BRAF突变的病例报告

Aggressive nodular melanoma: case report with an unusual BRAF mutation.

作者信息

El Bardai Sanae, El Agy Fatima, Mernissi Fatima Zahra, Kamal Dounia, Tahiri Elousrouti Layla, Chbani Laila, Hammas Nawal

机构信息

High Institute of Nursing Professions and Health Techniques, Fez, Morocco.

Biomedical and Translational Research Laboratory, Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdallah University, Fez, Morocco.

出版信息

Mol Biol Rep. 2025 Jul 9;52(1):688. doi: 10.1007/s11033-025-10803-w.

DOI:10.1007/s11033-025-10803-w
PMID:40632324
Abstract

BACKGROUND

Nodular melanoma (NM) is considered one of the most aggressive forms of skin cancer, accounting for approximately 10-15% of all melanoma cases. It tends to grow quickly and spread deeper into the skin's layers, providing fewer opportunities for early detection. NM often carries a poor prognosis due to local invasion and frequent distant metastases. BRAF mutations are frequently found in melanoma, with the most common mutation being a single-point mutation at codon 600 (typically V600E).

CASE PRESENTATION

We report a case of aggressive jugal nodular melanoma harboring an unusual BRAF mutation, C. 1789_1790 CT>TC.

METHODS

Genomic DNA was extracted from formalin-fixed paraffin-embedded (FFPE) tumor tissue. Sanger sequencing was employed to analyze exon 15 of the BRAF gene. The mutation was validated by bidirectional sequencing and interpreted using reference databases.

RESULTS

The identified BRAF mutation, c.1789_1790CT>TC, has been rarely reported in the literature. It results in a non-canonical amino acid substitution, potentially affecting kinase activity and therapeutic response.

CONCLUSION

This case underscores the clinical and molecular heterogeneity of nodular melanoma and highlights the importance of comprehensive BRAF mutation screening beyond the common V600E variant.

摘要

背景

结节性黑色素瘤(NM)被认为是皮肤癌中侵袭性最强的类型之一,约占所有黑色素瘤病例的10%-15%。它往往生长迅速,且会更深地扩散至皮肤各层,导致早期检测的机会较少。由于局部侵袭和频繁的远处转移,NM的预后通常较差。BRAF突变在黑色素瘤中经常被发现,最常见的突变是密码子600处的单点突变(通常为V600E)。

病例报告

我们报告一例侵袭性颊部结节性黑色素瘤病例,该病例携带一种不寻常的BRAF突变,即C. 1789_1790 CT>TC。

方法

从福尔马林固定石蜡包埋(FFPE)肿瘤组织中提取基因组DNA。采用Sanger测序法分析BRAF基因的第15外显子。通过双向测序验证该突变,并使用参考数据库进行解读。

结果

所鉴定出的BRAF突变c.1789_1790CT>TC在文献中鲜有报道。它导致一种非典型氨基酸替代,可能影响激酶活性和治疗反应。

结论

该病例强调了结节性黑色素瘤的临床和分子异质性,并突出了除常见的V600E变异之外进行全面BRAF突变筛查的重要性。

相似文献

1
Aggressive nodular melanoma: case report with an unusual BRAF mutation.侵袭性结节性黑色素瘤:伴有罕见BRAF突变的病例报告
Mol Biol Rep. 2025 Jul 9;52(1):688. doi: 10.1007/s11033-025-10803-w.
2
Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature.免疫组织化学作为检测黑色素瘤中BRAF-V600E突变的可靠方法:对当前已发表文献的系统评价和荟萃分析
J Surg Res. 2016 Jun 15;203(2):407-15. doi: 10.1016/j.jss.2016.04.029. Epub 2016 Apr 23.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
A comprehensive, multi-center, immunogenomic analysis of melanoma brain metastases.黑色素瘤脑转移的全面、多中心免疫基因组分析。
Acta Neuropathol Commun. 2025 Jun 2;13(1):123. doi: 10.1186/s40478-025-02035-7.
5
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
6
Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma.BRAF 突变与原发性黑色素瘤临床病理特征的荟萃分析
J Am Acad Dermatol. 2015 Jun;72(6):1036-46.e2. doi: 10.1016/j.jaad.2015.02.1113. Epub 2015 Mar 25.
7
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region.揭示头颈部黏膜黑色素瘤的分子图谱及临床相关分子异质性。
Histopathology. 2025 Aug;87(2):270-283. doi: 10.1111/his.15456. Epub 2025 Apr 15.
8
In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition.对接受免疫检查点抑制治疗的黑色素瘤患者血液中游离DNA上的BRAF、NRAS、KRAS、EGFR和PIK3CA突变进行深入评估。
J Exp Clin Cancer Res. 2025 Jul 12;44(1):202. doi: 10.1186/s13046-025-03457-w.
9
Can mutation abundance assess the biological behavior of BRAF-positive papillary thyroid carcinoma?突变丰度能否评估BRAF阳性甲状腺乳头状癌的生物学行为?
J Transl Med. 2025 Jul 1;23(1):704. doi: 10.1186/s12967-025-06493-4.
10
BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.甲状腺乳头状癌中的BRAF突变及其在制定初始治疗方案中的价值:一项系统评价和荟萃分析。
Medicine (Baltimore). 2012 Sep;91(5):274-286. doi: 10.1097/MD.0b013e31826a9c71.

本文引用的文献

1
Therapeutic Approaches to Mucosal Melanoma.黏膜黑色素瘤的治疗方法
Am Soc Clin Oncol Educ Book. 2025 Jun;45(3):e4733858. doi: 10.1200/EDBK-25-473858. Epub 2025 May 28.
2
Global burden of cutaneous melanoma incidence attributable to ultraviolet radiation in 2022.2022年归因于紫外线辐射的皮肤黑色素瘤发病的全球负担。
Int J Cancer. 2025 Sep 15;157(6):1110-1119. doi: 10.1002/ijc.35463. Epub 2025 May 27.
3
A Review of Melanoma Subtypes: Genetic and Treatment Considerations.黑色素瘤亚型综述:遗传学与治疗考量
J Surg Oncol. 2025 Mar;131(3):356-364. doi: 10.1002/jso.27953. Epub 2024 Oct 16.
4
Melanoma genomics - will we go beyond BRAF in clinics?黑色素瘤基因组学——我们在临床治疗上会超越 BRAF 吗?
J Cancer Res Clin Oncol. 2024 Sep 28;150(9):433. doi: 10.1007/s00432-024-05957-2.
5
Advances in Melanoma: From Genetic Insights to Therapeutic Innovations.黑色素瘤的进展:从基因洞察到治疗创新。
Biomedicines. 2024 Aug 14;12(8):1851. doi: 10.3390/biomedicines12081851.
6
Targeting All Alterations: The (Re)-Search Continues.靶向所有变异:研究持续进行。
JCO Precis Oncol. 2024 Feb;8:e2300670. doi: 10.1200/PO.23.00670.
7
BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers.黑色素瘤中的BRAF突变:生物学特性、治疗意义及循环生物标志物
Cancers (Basel). 2023 Aug 8;15(16):4026. doi: 10.3390/cancers15164026.
8
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort.转移性黑色素瘤中 V600E/K BRAF 突变以外的其他突变:在一个大型全国队列中的分子描述、频率和靶向治疗的有效性。
JCO Precis Oncol. 2022 Nov;6:e2200075. doi: 10.1200/PO.22.00075.
9
Implementation of an NGS panel for clinical practice in paraffin-embedded tissue samples from locally advanced and metastatic melanoma patients.在局部晚期和转移性黑色素瘤患者的石蜡包埋组织样本中实施用于临床实践的二代测序(NGS)基因检测板。
Explor Target Antitumor Ther. 2020;1(2):101-108. doi: 10.37349/etat.2020.00006. Epub 2020 Apr 28.
10
Targeted Therapy for Melanomas Without BRAF V600 Mutations.无 BRAF V600 突变黑色素瘤的靶向治疗。
Curr Treat Options Oncol. 2022 Jun;23(6):831-842. doi: 10.1007/s11864-022-00946-4. Epub 2022 Apr 5.